Funding for this research was provided by:
National Institute of Mental Health (K01 MH107256)
National Institute of Allergy and Infectious Diseases (R01 AI134036, R56 AI136499)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD090061)
National Center for Advancing Translational Sciences (UL1 TR000445)
March of Dimes Foundation
Vanderbilt Institute for Global Health Anne Potter Wilson Foundation fund
Text and Data Mining valid from 2019-05-20
Received: 10 January 2019
Accepted: 25 April 2019
First Online: 20 May 2019
Ethics approval and consent to participate
: This study conducted in accordance with the Declaration of Helsinki and was approved by the Human Research Protections Program at Vanderbilt University Medical Center, University of Jordan Institutional Review Board, and the Jordan Ministry of Health. All participants provided written informed consent prior to enrollment. To maintain participant confidentiality, unique study identification numbers were used in lieu of personal identifiers.
: Not applicable (no individual data).
: N.H. has received past vaccine and lab support from Sanofi, and previously served as a consultant for Moderna. A.J.R. has been a consultant for Pfizer. None of these past interests were related to the present study. We declare no other conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.